Table 1.
Median age in years, (range) | 72.9 (20–86) |
Male N (%) | 6 (60%) |
Caucasian N (%) | 9 (90%) |
Median BMI (kg/m2), range | 28.4 (20.2–32.4) |
Concomitant MG medications | |
Acetylcholinesterase inhibitors | 80% |
Corticosteroids | 60% |
Oral immunomodulators1 | 50% |
Median duration of MG in years, (range) | 0.8 (0.0–38.0) |
Baseline MGFA severity class | |
IIa | 20% |
IIIa | 30% |
IIIb | 40% |
Iva | 10% |
Primarily mycophenolate mofetil and azathioprine.